| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,252 |
2,664 |
$327K |
| 0002A |
|
265 |
256 |
$132K |
| 0001A |
|
234 |
227 |
$114K |
| 0124A |
|
110 |
110 |
$54K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
95 |
93 |
$51K |
| 0072A |
|
40 |
40 |
$22K |
| 0054A |
|
29 |
29 |
$16K |
| 0011A |
|
19 |
19 |
$10K |
| 0012A |
|
18 |
18 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
14 |
14 |
$9K |
| Q3014 |
Telehealth originating site facility fee |
19 |
18 |
$9K |
| 0071A |
|
13 |
12 |
$7K |
| 0004A |
|
13 |
13 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
27 |
25 |
$3K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
44 |
40 |
$2K |
| G0008 |
Administration of influenza virus vaccine |
99 |
97 |
$208.46 |
| Q2038 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) |
67 |
66 |
$147.92 |
| 90662 |
|
14 |
14 |
$52.80 |
| 90694 |
|
16 |
16 |
$11.39 |